無(wú)創(chuàng)機(jī)械通氣聯(lián)合藥物治療慢性阻塞性肺疾病患者急性加重期并嚴(yán)重Ⅱ型呼吸衰竭、肺性腦病療效觀察
發(fā)布時(shí)間:2019-06-02 03:46
【摘要】:正隨著無(wú)創(chuàng)呼吸機(jī)性能的改善,面罩的改進(jìn),無(wú)創(chuàng)機(jī)械通氣(NIPPV)已廣泛用于慢性阻塞性肺疾病(COPD)并呼吸衰竭患者的治療,循證醫(yī)學(xué)已證實(shí)了NIPPV在治療輕中度Ⅱ型呼吸衰竭的價(jià)值〔1〕。對(duì)于重度Ⅱ型呼吸衰竭〔動(dòng)脈二氧化碳分壓(PaCO2)≥80 mmHg〕伴神志障礙者不推薦使用;但已有研究〔2,3〕證實(shí),NIPPV對(duì)COPD并重度Ⅱ型呼吸衰竭、肺性腦病患者有益。本研究觀察NIPPV治療COPD急性加重(AECOPD)
[Abstract]:With the improvement of noninvasive ventilator performance and mask, noninvasive mechanical ventilation (NIPPV) has been widely used in the treatment of patients with chronic obstructive pulmonary disease (COPD) complicated with respiratory failure. Evidence-based medicine has confirmed the value of NIPPV in the treatment of mild to moderate type II respiratory failure (1). It is not recommended for patients with severe type II respiratory failure (arterial partial pressure of carbon dioxide (PaCO2) 鈮,
本文編號(hào):2490811
[Abstract]:With the improvement of noninvasive ventilator performance and mask, noninvasive mechanical ventilation (NIPPV) has been widely used in the treatment of patients with chronic obstructive pulmonary disease (COPD) complicated with respiratory failure. Evidence-based medicine has confirmed the value of NIPPV in the treatment of mild to moderate type II respiratory failure (1). It is not recommended for patients with severe type II respiratory failure (arterial partial pressure of carbon dioxide (PaCO2) 鈮,
本文編號(hào):2490811
本文鏈接:http://sikaile.net/yixuelunwen/huxijib/2490811.html
最近更新
教材專著